It is evident that experimental modifications may exert profound effects on heart metabolism. It is also evident from these studies and from Zierler's report (49) h ow important it is to assess blood flow. The use of extraction ratios ((A-V)/A) as a way of negating blood flow in determining uptake is not valid unless flow is constant. In the present studies we have found the coronary blood flow (CBF) very labile in the unanesthetized dog and subject to change under the slightest provocation.
Since the quantity of substrate taken up is dependent upon flow, measurement of flow rate in determining uptake is imperative. Narcosis also exerts a profound effect on FFA metabolism (12) Under conditions similar to the present study, Gold and Spitzer (16) showed that there was no difference between the uptake and oxidation of palmitic and oleic acids in the myocardium.
Since these two acids make up 70 % of the total FFA, palmitic acid can be recognized as a good representative fatty acids. The experiment was initiated with a primer dose of palmitate-1 -r4C (approximately 7.0 PC) followed by a continuous infusion of the isotope for the entire experiment at the rate of approximately 0.5 pc/min for 240 min. To estimate the rate of oxidation of the fatty acids in the whole body from the rate of appearance of 14C02 in the expired gases, a correction has to be made due to the slow exchange between labeled CO2 and unlabeled bicarbonate pools. Since the 14C02 output rises in the form of an exponential curve approaching an asymptotic value, in about 4 hr in dogs (25) and in 8 hr in man (28), it is inaccurate to apply the correction factor before 1 hr in the dog and 3 hr in man. In addition, it is our experience that the coronary sinus-artery (CS-A) difference of 14C02 does not reach a steady value until 40-60 min after the start of infusion. Also, the rate of incorporation of labeled FFA into plasma triglycerides (TG) does not reach a steady state until l-2 hr after start of infusion (34). In the early experiments, an equilibrium period of 1 hr was used, but this was not sufficient to achieve a steady state for all the factors mentioned above. Therefore, a Z-hr period was tested and found to produce a steady state. In all subsequent experiments the initial sample was taken after 120 min of infusion.
After 60 or 120 min, dilute respiratory gas samples were collected and analyzed as previously described (36) A-V FFA-14C (dpm/ml) X plasma flow (ml/100 g per min) A FFA SA (dpm/pEq) where A = arterial concentration and V = venous concentration.
Myocardial FFA oxidation to CO2 was deter- 
RESULTS
The metabolism of FFA in the total body and in the heart was compared in three different kinds of experiments (Fig. 1) . To evaluate the metabolic myocardial changes during increased demand, exercise (experiment A) was started after more than 2 hr of rest. To evaluate the effects of low or high FFA level, 10 % glucose (experiment B) or NE (experiment C), infusions were started after the rest period. A single control and two experimental samples were drawn. All experiments were preceded by an 18-hr fast that produced a basal arterial FFA concentration varying from 0.4 to 1.0 pEq/ml in the resting unanesthetized 60 120 180
dog. To ensure somewhat higher FFA levels for the glucose infusion experiments, the fast was extended to 24 hr. By producing slightly higher FFA levels, the FFA-lowering effect of glucose was enhanced.
In the first group of experiments (A), after a rest period of 150 min, the dog exercised on a treadmill for 110 min. As was shown previously (27), the FFA rises in the highly trained dog. There is an increase in myocardial FFA uptake and oxidation rate, and the total body turnover also increases. The myocardial RQ falls rapidly as does the ventilatory RQ. In the resting animal (B), the FFA level was decreased by a 10 % glucose infusion.
Myocardial FFA oxidation decreased sharply. Myocardial RQ rose from 0.7 to over 9.9, and the ventilatory RQ rose similarly. In experiment C, infusion of NE induced a marked rise of FFA concentration to over 2.0 pEq/ml. The myocardial FFA uptake and oxidation also rose and the myocardial RQ decreased.
An uptake of FFA by the heart is seen in all our experimental conditions (Table 1) . Norephinephrine and exercise produced a significantly increased uptake (P < .OOl), and 10 % glucose infusion was observed to significantly decrease uptake (P < .OOl). No statistical difference was observed between the arterial and coronary sinus FFA SA in the control or experimental conditions (Table  1) . Arterial levels of FFA during NE infusion or exercise were higher than controls (P < .OOl) in both cases, while it was lower for glucose infusion (P < .OO 1). Myocardial FFA uptake ((A -CS) X flow), removal (calculated from palmitate J4C uptake), and oxidation are compared in Table 2 . In the control (at rest), the heart MILLER, YUM, AND DURHAM (Fig. 2) . In the control animals, the regression coefficient (P < .OOl level) was 0. In all experiments, the TGFA A-CS difference across the heart was inconsistent and variable (Table  3 ). The control value of .022 pmole/ml is actually smaller than the SE; hence, experimental changes in this difference probably would not be detected. While it may appear that the 10 % glucose infusion increased arterial TGFA concentrations, it was not statistically significant. During rest (control) and exercise, however, the heart takes up lactic acid (Table 4) . When NE was infused, the uptake of lactate decreased or in some cases became an output.
Differences from the control were significant at P < .OOl . Arterial concentration did not change significantly during NE infusion nor did CBF. The 10 % glucose infusion decreased myocardial uptake of lactate in most cases, but the extent of the decrease was variable (0.1-10 mg/ 100 g per min). A Student t test showed no significant difference between the mean of the control and the mean of the 10 % glucose infusion.
But nonparameteric analysis showed a significant difference at P < .Ol. Since these dogs were highly trained and the exercise was only moderate, the arterial lactate level did not rise significantly (22) and the uptake of lactate did not increase over the control.
Because of the very low value for myocardial glucose uptake, significant changes due to NE or exercise could not be observed (Table  4) . The 10 % glucose infusion did indeed increase the amount of glucose taken up by the heart and also increased the myocardial RQ. Again, only 10 % glucose increased arterial glucose concentration.
DISCUSSION
In spite of the great variation in arterial FFA concentrations (0.2-2.0 ~Eq/ml) in this study, the FFA SA coming from the heart was the same as that of arterial blood (Table 1 ). In contrast, Most et al. (37) reported FFA SA in coronary sinus blood to be lower than in arterial. They suggested that in coronary sinus blood may be diluted by release of unlabeled FFA from tissue stores and hydrolysis of circulating TG by myocardial lipoprotein lipase. A possible explanation for the differences may be in the experimental design of the two investigations.
In the present study palmitate-14C was infused for 2 hr prior to the first sample collection, whereas Most and his colleagues utilized a total infusion time of 20-40 min. As we have demonstrated in a previous publication (34) the plasma fatty acid incorporation into plasma TG reached a steady state only after a I-to 2-hr period of infusion, at which time the TGFA SA approaches that of the FFA SA. Assuming that lipoprotein lipase in the heart was hydrolyzSince the myocardium is able to pick up circulating FFA and they can be deposited in the muscle (43), the myocardial fat became labeled after some time. Thus, early in the experiment mobilized fatty acid would be relatively unlabeled.
Later, as more fatty acid is labeled and mobilized, there would be less dilution. Most suggested two possibilities for the discrepancies between the SA of FFA of the arterial blood and that coming from the coronary sinus. One is that the palmitateJ*C-albumin complex may have led to preferential uptake, and the other is that the myocardium may treat the palmitate differently. The former possibility does not seem to be so because of the constant FFA SA as it passes through the heart. Certainly an increase in equilibration time would not change the complex. Most also discarded this possibility. Even though some investigators have reported a slight myocardial preference for oleic acid (6, 40), this was not found by Miller et al. (35) , Gold and Spitzer (16) , and Most et al. (37) . Thus, the latter explanation also was discarded. Therefore, the constancy of the FFA SA as it passes through the heart depends upon the mobilization or hydrolysis of the fat either in the heart or blood.
The importance of steady state was again observed when uptake based on chemical differences, removal based on isotope differences, and oxidation were compared in control animals ( Table 2 ). The results were remarkably similar, which showed that the labeled palmitate was bound to the albumin in a physiologically equivalent manner and was not selectively taken up by the myocardium. During the NE or 10 % glucose infusion (Table 2) , there were no statistical differences between myocardial FFA uptake, removal, and oxidation. Whereas there was no statistical difference during exercise between the means of the three calculations, all of the removal rates were less than the oxidation rates. The range of values varied from 1.5 to 30 pEq/lOO g per min, which leads to the large standard error of the mean. Two possible explanations for this discrepancy during exercise might be found in: 1) the rapid changes in FFA turnover would produce wide variation of FFA level which in turn would change the uptake, removal, and oxidation; or 2) the mobilization and utilization of endogenous myocardial lipid, which would result in a higher oxidation rate than removal rate. Since oxidation was based on 14C02 one must assume that during the preexercise 2hr infusion the endogenous heart lipids were labeled.
Although virtually all of the myocardial uptake was oxidized, it is possible that at rest small quantities, amounts undetectable by our methods, could be stored and later oxidized, hence increasing 14C02 released by the heart.
A third possibility is that some of the 14COp produced during the control period (at rest) was derived in part from the stored myocardial lipid. The breakdown of a small portion of these lipids could occur all the time, with a substantial increase during exercise. Skeletal muscle experiments by Have1 et al. (22) showed that during heavy exercise, FFA entering the working muscle appeared to be completely oxidized, but some fatty acids also entered into the storage pools. It would appear that endogenous lipid is available and is used for energy in the myocardium.
Further evidence indicating possible oxidation of endogenous lipid is found in Fig. 2 . The exercise regression line is above the equal removal-oxidation line. Under all the conditions examined thus far, about 10 % of the total body FFA turnover was utilized for energy by the myocardium.
At rest, virtually 100 % of the FFA taken up by the heart was oxidized (Table 2) . Within the limits of our experimental procedures and calculations, all of the FFA uptake was oxidized during the NE and glucose infusion experiments. Under all the reported conditions the percent of total body FFA turnover oxidized by the heart was constant, about 10% except when NE was infused, when only 5 % was oxidized.
Thus, even though arterial FFA concentration was increased some 30 % in NE infusions, heart muscle took up only enough to balance the rate of oxidation despite a threefold rise in turnover. There is also evidence for increased total body storage of fatty acids during NE infusion. While exercise produces an increase in oxidation to about 65 % of the turnover, the percent oxidized remains at 25 % during NE infusion although in both cases the total body turnover increases. The conclusion drawn here is that there is increased total body esterification and storage during NE infusion. It seerns that the same thing happens in the heart. Cowley et al. (8) recently showed that NE had a direct effect on FFA oxidation by the myocardium in unanesthetized dogs. But their experimental design did not permit the estimation of the degree to which it increased oxidation.
In the present study, the systemic lipolytic action of NE (increase in FFA total body turnover) was greater than the effect on the total body FFA oxidation.
While it is well established that FFA is taken up by the heart (19), uptake of TGFA appears to be more controversial. Our data indicate little or no TGFA A-V differences across the heart (Table  3) . But it must be stressed that, in the dog, the fasting TG level is very low as are A-CS differences.
If real differences existed, they were not MILLER, YUM, AND DURHAM detectable by the procedure used. But the varying flow, which was high in the negative experiments (output), produced an increased bias to these data and seemed to show an average, albeit not significant, output of TG. This, coupled with a small A-CS difference, would produce invalid, confusing data. in their study showed an uptake in every subject. Willebrands (47) indicated that if only 5 mg/min TG were oxidized 100 % of the myocardial 02 consumption would be used. Therefore, only 1 mg/min uptake could account for 20% of the 02 consumption.
A small difference such as this, across the heart, would not be detected by our analytical methods. Ballard et al.
(1) reported an uptake by the heart in vivo of esterified fatty acid that included TGFA. This uptake was determined indirectly and was inconclusive.
On the other hand, uptake of TG by the isolated perfused heart has been shown repeatedly (9, 11, 20, 23) . Therefore, it is probable that some TG is taken up by the myocardium but a procedure other than ours must be used to ascertain the degree of uptake.
In this study lactate was taken up by the myocardium in every control dog, an observation made by several other investigators (5, 6). The infusion of 10 % glucose decreased the uptake, seemingly sparing the lactate. The uptake of lactic acid decreases and even becomes an output when NE is infused. This change due to NE could explain the decrease in the "extraction ratio" in disease or stress situations. Goodale and coworkers (17, 18) , showed that a variety of disease states in humans and animals decreased lactate uptake by the heart. One explanation for the decrease in lactic acid extraction due to NE is that local areas of myocardial hypoxia might exist. While Bing and his colleagues (5) felt that extraction was dependent on a threshold, Krasnow et al. (31) described it as a problem of net balance. Accepting the latter supposition, an increase in lactic acid production in the heart (but not in the rest of the body) due to NE infusion would decrease the A-V difference across the heart, which would then appear to result in an overall output. An alternative explanation for the decrease in lactate uptake due to NE might be found in substrate concentration and utilization. Norepinephrine infusion increased arterial FFA concentration and FFA myocardial uptake and oxidation (see Table 1 ). This would exert a lactic-acid sparing effect in the heart. Evans and Opie (12) agree with the latter explanation.
They stated that, "Myocardial lactate uptake for any given arterial level will be decreased if intracellular glycolysis increases or if increased FFA uptake due to norepinephrine inhibits pyrivate entry into the Krebs Cycle through competition for available
CoA." On the other hand, Krasnow (29) reported that mild physical exercise in his subjects did not change lactate extraction.
No increase in lactate uptake by the heart in moderate exercise was noted in the dog experiments, even though the arterial lactic acid concentration rose.
A third possibility is that the NE mobilized glucose from glycogen in the heart muscle. This could produce the additional lactate if it were metabolized that far. But, in our experience, with constant infusion of NE at rates of 0. l-l .O pg/min, we have never seen a systemic increase in either lactate or glucose. Therefore, it does not seem that this is a factor. The use of radioactive infusion of lactate could help to decide which alternative is correct, if they are, indeed, mutually exclusive. There is no doubt that the heart uses glucose for energy. Glucose uptake in our preparation was low. Bing (4) reported an equal uptake of lactate and glucose. In our preparation it was more like a fifth in favor of lactate. Bing (3) reported about 35 % of the myocardialO2 consumption was spent for carbohydrate.
In the present studies, this value is somewhat lower. The problem in this preparation is that the uptake of glucose by the heart is so low that precise measurements are difficult. But it seems that lactate and not glucose is the major energy source supplying carbohydrate. Goodale and Hackel (17) found that the dog heart utilizes carbohydrate in proportion to its arterial concentration. In fact, when we increased glucose levels in this investigation we saw not only an increase in glucose uptake but also in the myocardial RQ. In conclusion, under normal conditions the heart metabolically prefers fatty acid as a substrate for energy. Even during glucose infusion, the heart muscle still uses 
